Literature DB >> 11705730

Induction of Hsp60 by Photofrin-mediated photodynamic therapy.

J G Hanlon1, K Adams, A J Rainbow, R S Gupta, G Singh.   

Abstract

Photodynamic therapy (PDT) invokes a number of cellular responses. Other studies have shown that PDT induces transcription and translation of heat shock proteins (Hsps). The expression of mitochondrial heat shock protein, Hsp60, was measured following in vitro Photofrin-mediated PDT in the colon cancer cell line HT29 and its PDT-induced resistant variant HT29-P14 as well as the radiation-induced fibrosarcoma cells RIF-1 and its PDT-induced resistant variant, RIF-8A. Basal levels of Hsp60 were found to be similar in the two murine cell lines. In the human model, the resistant HT29-P14 cell line showed a small increase in basal levels relative to its parental population. Incubation with Photofrin (PII) alone or photosensitization caused a significant increase in Hsp60 levels in all cell lines as determined by flow cytometry. A dose-dependent and temporal relationship for PDT response was observed, maximum levels were detected 6-8 h post PDT, at which time, Hsp60 induction was found to be significantly greater in the two resistant variants. Induction in the RIF cells was also found to be greater after incubation with PII alone at the highest doses tested. These results indicate that the presence of PII and the subsequent oxidative stress of PDT can induce Hsp60 and implicated it as a common factor that may contribute to the resistance observed in the induced resistant cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11705730     DOI: 10.1016/s1011-1344(01)00189-0

Source DB:  PubMed          Journal:  J Photochem Photobiol B        ISSN: 1011-1344            Impact factor:   6.252


  13 in total

Review 1.  Photodynamic therapy and anti-tumour immunity.

Authors:  Ana P Castano; Pawel Mroz; Michael R Hamblin
Journal:  Nat Rev Cancer       Date:  2006-07       Impact factor: 60.716

Review 2.  Tumor cell survival pathways activated by photodynamic therapy: a molecular basis for pharmacological inhibition strategies.

Authors:  Mans Broekgaarden; Ruud Weijer; Thomas M van Gulik; Michael R Hamblin; Michal Heger
Journal:  Cancer Metastasis Rev       Date:  2015-12       Impact factor: 9.264

Review 3.  Mechanisms of resistance to photodynamic therapy.

Authors:  A Casas; G Di Venosa; T Hasan
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

4.  Mechanisms in photodynamic therapy: part two-cellular signaling, cell metabolism and modes of cell death.

Authors:  Ana P Castano; Tatiana N Demidova; Michael R Hamblin
Journal:  Photodiagnosis Photodyn Ther       Date:  2005-03       Impact factor: 3.631

Review 5.  Photodynamic therapy of cancer: an update.

Authors:  Patrizia Agostinis; Kristian Berg; Keith A Cengel; Thomas H Foster; Albert W Girotti; Sandra O Gollnick; Stephen M Hahn; Michael R Hamblin; Asta Juzeniene; David Kessel; Mladen Korbelik; Johan Moan; Pawel Mroz; Dominika Nowis; Jacques Piette; Brian C Wilson; Jakub Golab
Journal:  CA Cancer J Clin       Date:  2011-05-26       Impact factor: 508.702

6.  Tumor response to mTHPC-mediated photodynamic therapy exhibits strong correlation with extracellular release of HSP70.

Authors:  Soumya Mitra; Benjamin R Giesselman; Francisco J De Jesús-Andino; Thomas H Foster
Journal:  Lasers Surg Med       Date:  2011-09       Impact factor: 4.025

7.  Analysis of the bacterial heat shock response to photodynamic therapy-mediated oxidative stress.

Authors:  Tyler G St Denis; Liyi Huang; Tianhong Dai; Michael R Hamblin
Journal:  Photochem Photobiol       Date:  2011-02-22       Impact factor: 3.421

8.  Investigation of copper-cysteamine nanoparticles as a new photosensitizer for anti-hepatocellular carcinoma.

Authors:  Xuejing Huang; Fengjie Wan; Lun Ma; Jonathan B Phan; Rebecca Xueyi Lim; Cuiping Li; Jiagui Chen; Jinghuan Deng; Yasi Li; Wei Chen; Min He
Journal:  Cancer Biol Ther       Date:  2019-02-06       Impact factor: 4.742

9.  The effects of Photofrin-mediated photodynamic therapy on the modulation of EGFR in esophageal squamous cell carcinoma cells.

Authors:  Pei-Wen Yang; Mien-Chie Hung; Ching-Yueh Hsieh; En-Chi Tung; Ying-Hao Wang; Jui-Chang Tsai; Jang-Ming Lee
Journal:  Lasers Med Sci       Date:  2012-05-15       Impact factor: 3.161

Review 10.  Chlamydia trachomatis infection and anti-Hsp60 immunity: the two sides of the coin.

Authors:  Francesco Cappello; Everly Conway de Macario; Valentina Di Felice; Giovanni Zummo; Alberto J L Macario
Journal:  PLoS Pathog       Date:  2009-08-28       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.